Dimethyl Fumarate

Back to search

Molecule Structure

Scientific Name

Dimethyl Fumarate

Description of the Drug

Dimethyl fumarate is a medication used to treat patients with the relapsing-remitting form of multiple sclerosis.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB08908

Brand Name(s)

Tecfidera

Company Owner(s)

Mylan Pharmaceuticals Inc, Lupin Inc, Cipla Ltd, Hetero Labs Ltd Unit Iii, Amneal Eu Ltd, Msn Laboratories Private Ltd, Glenmark Pharmaceuticals Ltd, Twi Pharmaceuticals Inc, Pharmathen Sa, Zydus Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Kelch-like ECH-associated protein 1 SINGLE PROTEIN INHIBITOR CHEMBL2069156

Unichem Links

SureChEMBL SCHEMBL41835
PharmGKB PA166152838
WDI DIMEFUMAR
DrugBank DB08908
PubChem: Thomson Pharma 15146755
PubChem 637568
Mcule MCULE-4208733984
NMRShiftDB 74928
LINCS LSM-45569
Nikkaji J45.019G J502.486B
PDBe EOU
BindingDB 50504654
DrugCentral 4757
ChemicalBook CB4854003 CB6712800
Guide to Pharmacology 7045
GSRS 00a0cb5d-d9bd-496f-be14-2edc89bc6e0a
rxnorm TECFIDERA DIMETHYL FUMARATE
PubChem: Drugs of the Future 99431554
ChEBI 76004
ZINC ZINC000003843378